cyclocreatine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
cyclocreatine: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "The gene defect in Huntington's disease (HD) may result in an impairment of energy metabolism." | 1.30 | Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. ( Beal, MF; Ferrante, RJ; Jenkins, BG; Kaddurah-Daouk, R; Matthews, RT; Rosen, BR; Yang, L, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matthews, RT | 1 |
| Yang, L | 1 |
| Jenkins, BG | 1 |
| Ferrante, RJ | 1 |
| Rosen, BR | 1 |
| Kaddurah-Daouk, R | 1 |
| Beal, MF | 1 |
1 other study available for cyclocreatine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Antineoplastic Agents; Creatine; Creatinin | 1998 |